The results of treating these two kinds of tumor‐derived xenografts with the same method showed that SG635‐SF could block CD47 expression in HO8910 xenografts effectively and recruit relative murine immune cells, including macrophages and NK cells (Fig. 4A). The gene discussed is CD47; the disease is neoplasm.